FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
By Meg Tirrell and Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the matter told CNN. The terms need to be negotiated before Novavax’s vaccine could be granted full
Continue Reading